Published in Lancet on January 21, 2009
A new generation of trade policy: potential risks to diet-related health from the trans pacific partnership agreement. Global Health (2013) 1.69
Tackling non-communicable diseases in low- and middle-income countries: is the evidence from high-income countries all we need? PLoS Med (2013) 1.67
Managing the pursuit of health and wealth: the key challenges. Lancet (2009) 1.34
Trade and investment liberalization and Asia's noncommunicable disease epidemic: a synthesis of data and existing literature. Global Health (2014) 1.02
The potential for bi-lateral agreements in medical tourism: A qualitative study of stakeholder perspectives from the UK and India. Global Health (2011) 0.92
Commentary: Moving towards policy coherence in trade and health. J Public Health Policy (2015) 0.82
World health dilemmas: Orphan and rare diseases, orphan drugs and orphan patients. World J Methodol (2014) 0.80
Capacity building for global health diplomacy: Thailand's experience of trade and health. Health Policy Plan (2014) 0.79
Medical tourism: a fad or an opportunity Comment on "Patient mobility in the global marketplace: a multidisciplinary perspective". Int J Health Policy Manag (2014) 0.75
Assessing the Health Impact of Trade: A Call for an Expanded Research Agenda Comment on "The Trans-Pacific Partnership: Is It Everything We Feared for Health?" Int J Health Policy Manag (2016) 0.75
The Trans-Pacific Partnership: Should We "Fear the Fear"? Comment on "The Trans-Pacific Partnership: Is It Everything We Feared for Health?" Int J Health Policy Manag (2016) 0.75
Trade is central to achieving the sustainable development goals: a case study of antimicrobial resistance. BMJ (2017) 0.75
Policy forum: public health. The health and wealth of nations. Science (2000) 4.29
Trade and social determinants of health. Lancet (2009) 3.47
Trade in health-related services. Lancet (2009) 1.88
Trade, TRIPS, and pharmaceuticals. Lancet (2009) 1.63
Measuring the globalization of health services: a possible index of openness of country health sectors to trade. Health Econ Policy Law (2006) 1.54
Managing the pursuit of health and wealth: the key challenges. Lancet (2009) 1.34
Health and wealth. Nat Med (2002) 0.93
Looking inside the tobacco industry: revealing insights from the Guildford Depository. Addiction (2004) 3.86
Unlocking the corporate documents of British American Tobacco: an invaluable global resource needs radically improved access. Lancet (2004) 3.76
Corporate social responsibility and access to policy élites: an analysis of tobacco industry documents. PLoS Med (2011) 1.82
Communicable disease control: a 'Global Public Good' perspective. Health Policy Plan (2004) 1.64
"Efforts to Reprioritise the Agenda" in China: British American Tobacco's Efforts to Influence Public Policy on Secondhand Smoke in China. PLoS Med (2008) 1.51
Ten years of the Global Alliance for Vaccines and Immunisation. BMJ (2010) 1.48
Health and foreign policy. Bull World Health Organ (2006) 1.46
Managing the pursuit of health and wealth: the key challenges. Lancet (2009) 1.34
TRIPS, the Doha declaration and paragraph 6 decision: what are the remaining steps for protecting access to medicines? Global Health (2007) 1.32
Foreign policy, trade and health: at the cutting edge of global health diplomacy. Bull World Health Organ (2007) 1.27
Corporate Power and Social Policy: The Political Economy of the Transnational Tobacco Companies. Glob Soc Policy (2009) 1.23
Framing global health: the governance challenge. Glob Public Health (2012) 1.21
Trade policy, health, and corporate influence: British American tobacco and China's accession to the World Trade Organization. Int J Health Serv (2010) 1.18
Global health and foreign policy. Epidemiol Rev (2010) 1.11
Framing and global health governance: key findings. Glob Public Health (2012) 1.05
The Limits of Corporate Social Responsibility: Techniques of Neutralization, Stakeholder Management and Political CSR. J Bus Ethics (2013) 1.04
Type A behavior pattern and coronary heart disease: Philip Morris's "crown jewel". Am J Public Health (2012) 1.01
A race to the death: British American Tobacco and the Chinese Grand Prix. Lancet (2004) 0.99
The national security implications of HIV/AIDS. PLoS Med (2006) 0.97
The "father of stress" meets "big tobacco": Hans Selye and the tobacco industry. Am J Public Health (2010) 0.94
Are transnational tobacco companies' market access strategies linked to economic development models? A case study of South Korea. Glob Public Health (2013) 0.87
Creating demand for foreign brands in a 'home run' market: tobacco company tactics in South Korea following market liberalisation. Tob Control (2012) 0.86
Assessing trade in health services in countries of the Eastern Mediterranean from a public health perspective. Int J Health Plann Manage (2010) 0.84
From policy coherence to 21st century convergence: a whole-of-society paradigm of human and economic development. Ann N Y Acad Sci (2014) 0.84
Civil Society Organizations and the Functions of Global Health Governance: What Role within Intergovernmental Organizations? Glob Health Gov (2010) 0.84
Corporate social responsibility: serious cause for concern. Tob Control (2006) 0.83
Whole-of-society approach for public health policymaking: a case study of polycentric governance from Quebec, Canada. Ann N Y Acad Sci (2014) 0.83
'A major lobbying effort to change and unify the excise structure in six Central American countries': How British American Tobacco influenced tax and tariff rates in the Central American Common Market. Global Health (2011) 0.81
Global health and national security: the need for critical engagement. Med Confl Surviv (2006) 0.79
To 'enable our legal product to compete effectively with the transit market': British American Tobacco's strategies in Thailand following the 1990 GATT dispute. Glob Public Health (2015) 0.76
"Fighting a hurricane": tobacco industry efforts to counter the perceived threat of Islam. Am J Public Health (2015) 0.76
The limits of global health diplomacy: Taiwan's observer status at the world health assembly. Global Health (2014) 0.76
Globalisation and health. Informed and open debate on globalisation and health is needed. BMJ (2002) 0.75
Is the UN broken, and can we fix it? BMJ (2005) 0.75
Canada: Twisting the legacy name. Tob Control (2014) 0.75
Convergent innovation for sustainable economic growth and affordable universal health care: innovating the way we innovate. Ann N Y Acad Sci (2014) 0.75
Reed Elsevier and the arms trade revisited. Lancet (2007) 0.75